Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004158105 | SCV003640873 | uncertain significance | not specified | 2022-08-31 | criteria provided, single submitter | clinical testing | The c.743A>T (p.Q248L) alteration is located in exon 8 (coding exon 8) of the ATP13A5 gene. This alteration results from a A to T substitution at nucleotide position 743, causing the glutamine (Q) at amino acid position 248 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |